THE BEST SIDE OF 2'

Contraindicated (one)bortezomib will enhance the degree or result of mavacamten by impacting hepatic enzyme CYP2C19 metabolism. Contraindicated. Solid or reasonable CYP2C19 inhibitors may well enhance mavacamten systemic exposure, resulting in coronary heart failure resulting from systolic dysfunction.Significant: The drug info on this page is supp